Lipocine Revenue 2012-2019 | LPCN

Lipocine revenue from 2012 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Lipocine Annual Revenue
(Millions of US $)
2018 $0
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $8
2011 $
Lipocine Quarterly Revenue
(Millions of US $)
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018 $0
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q2 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.046B $0.000B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.237B 34.65
Astellas Pharma (ALPMY) Japan $28.255B 13.85
Takeda Pharmaceutical (TAK) Japan $27.794B 8.16
Eisai (ESALY) Japan $16.077B 27.64
UCB SA (UCBJF) Belgium $15.866B 0.00
Grifols, S.A (GRFS) Spain $14.700B 18.59
Merck (MKGAF) Germany $13.435B 18.33
IPSEN SA ADR (IPSEY) France $10.629B 0.00
Sage Therapeutics (SAGE) United States $9.716B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $9.194B 20.10
Neurocrine Biosciences (NBIX) United States $7.823B 0.00
Catalent (CTLT) United States $7.787B 31.25
Jazz Pharmaceuticals (JAZZ) Ireland $7.540B 10.34
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.878B 9.58
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.944B 17.38
Evotec AG (EVTCY) Germany $4.268B 45.82
Tilray (TLRY) Canada $4.214B 0.00
FibroGen (FGEN) United States $3.929B 0.00
United Therapeutics (UTHR) United States $3.351B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.195B 11.47
Arrowhead Pharmaceuticals (ARWR) United States $2.574B 387.86
PTC Therapeutics (PTCT) United States $2.510B 0.00
Xencor (XNCR) United States $2.499B 68.21
Zogenix (ZGNX) United States $1.999B 0.00
Portola Pharmaceuticals (PTLA) United States $1.776B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.705B 82.56
Enanta Pharmaceuticals (ENTA) United States $1.669B 22.80
Ironwood Pharmaceuticals (IRWD) United States $1.618B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.467B 0.00
USANA Health Sciences (USNA) United States $1.394B 12.12
Corcept Therapeutics (CORT) United States $1.220B 17.41
ArQule (ARQL) United States $1.211B 0.00
Aerie Pharmaceuticals (AERI) United States $1.202B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.105B 3.98
Radius Health (RDUS) United States $1.024B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.973B 0.00
Endo (ENDP) Ireland $0.927B 1.49
Spectrum Pharmaceuticals (SPPI) United States $0.904B 0.00
Concordia (CXRXF) Canada $0.729B 0.00
Organogenesis Holdings (ORGO) United States $0.707B 0.00
Aptorum Group (APM) China $0.672B 0.00
TherapeuticsMD (TXMD) United States $0.603B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.594B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.581B 0.00
GlycoMimetics (GLYC) United States $0.547B 0.00
Translate Bio (TBIO) United States $0.517B 0.00
Akebia Therapeutics (AKBA) United States $0.496B 0.00
ChemoCentryx (CCXI) United States $0.493B 0.00
Karyopharm Therapeutics (KPTI) United States $0.489B 0.00
Dova Pharmaceuticals (DOVA) United States $0.480B 0.00
Dermira (DERM) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.464B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.458B 23.09
Indivior (INVVY) United States $0.434B 1.57
Corbus Pharmaceuticals Holdings (CRBP) United States $0.426B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.421B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.419B 0.00
CV Sciences (CVSI) United States $0.416B 0.00
Flexion Therapeutics (FLXN) United States $0.410B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.400B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Collegium Pharmaceutical (COLL) United States $0.381B 0.00
Innate Pharma SA (IPHYF) France $0.366B 0.00
ImmunoGen (IMGN) United States $0.365B 0.00
Harpoon Therapeutics (HARP) United States $0.365B 0.00
CannTrust Holdings (CTST) Canada $0.364B 0.00
OptiNose (OPTN) United States $0.330B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.299B 0.00
Concert Pharmaceuticals (CNCE) United States $0.272B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.260B 0.00
Aratana Therapeutics (PETX) United States $0.244B 0.00
Lannett Co Inc (LCI) United States $0.228B 2.22
Recro Pharma (REPH) United States $0.223B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.219B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.201B 0.00
IMV INC (IMV) Canada $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Calithera Biosciences (CALA) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.160B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.148B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.143B 0.00
Majesco Entertainment (PTE) United States $0.139B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.128B 0.00
DURECT (DRRX) United States $0.107B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.093B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 0.00
Capnia (SLNO) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 63.00
MediWound (MDWD) Israel $0.087B 0.00
Genocea Biosciences (GNCA) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.084B 8.40
Avadel Pharmaceuticals (AVDL) Ireland $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.083B 0.00
Cardiome Pharma (CORV) Canada $0.082B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Novan (NOVN) United States $0.074B 0.00
Neos Therapeutics (NEOS) United States $0.072B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00